Clinical results of ab interno trabeculotomy using the trabectome for open-angle glaucoma: The mayo clinic series in Rochester, Minnesota

Yachna Ahuja, Son Ma Khin Pyi, Mehrdad Malihi, David O. Hodge, Arthur J Sit

Research output: Contribution to journalArticle

71 Citations (Scopus)

Abstract

Purpose To determine outcomes of ab interno trabeculotomy for treatment of open-angle glaucoma (OAG). Design Retrospective interventional single-surgeon, single-center case series. Methods Data were collected from 246 patients undergoing ab interno trabeculotomy between September 1, 2006, and December 1, 2010, with 3 months' follow-up or longer. Kaplan-Meier analysis was performed using Criteria A (postoperative intraocular pressure [IOP] ≤21 mm Hg or ≥20% reduction from preoperative IOP) and Criteria B (IOP ≤18 mm Hg and ≥20% reduction in IOP). Failure included increased glaucoma medications or subsequent surgery. Failure risk factors were identified using Cox proportional hazards ratio (HR). Results Of 88 cases of ab interno trabeculotomy-only and 158 cases of ab interno trabeculotomy with cataract extraction, the retention rate was 70% for 1 year and 62% for 2 years. Preoperative mean IOP was 21.6 ± 8.6 mm Hg; the number of glaucoma medications was 3.1 ± 1.1. At 24 months postoperatively, mean IOP was reduced 29% to 15.3 ± 4.6 mm Hg (P < 0.001) and the number of glaucoma medications was reduced 38% to 1.9 ± 1.3 (P < 0.001) with a success rate of 62% (95% CI, 56%-68%) using Criteria A and 22% (95% CI, 16%-29%) using Criteria B. Failure risk factors using Criteria A included primary OAG (HR 3.14, P < 0.01, 95% CI, 1.91-5.17) and past argon laser trabeculoplasty (HR 1.81, P < 0.01, 95% CI, 1.18-2.77). Using Criteria B, the HR for pseudoexfoliative glaucoma was 0.43 (P < 0.01, 95% CI 0.27-0.67). Of the cases, 66 (26.8%) required subsequent surgery on an average of 10 months (2 days to 3.2 years) after ab interno trabeculotomy. Conclusions For criteria involving IOP ≤18 mm Hg, the 24-month survival of ab interno trabeculotomy is low. This surgery is appropriate for patients requiring a target IOP of 21 mm Hg or above.

Original languageEnglish (US)
JournalAmerican Journal of Ophthalmology
Volume156
Issue number5
DOIs
StatePublished - Nov 2013

Fingerprint

Trabeculectomy
Open Angle Glaucoma
Intraocular Pressure
Glaucoma
Cataract Extraction
Argon
Kaplan-Meier Estimate
Lasers
Survival

ASJC Scopus subject areas

  • Ophthalmology

Cite this

Clinical results of ab interno trabeculotomy using the trabectome for open-angle glaucoma : The mayo clinic series in Rochester, Minnesota. / Ahuja, Yachna; Ma Khin Pyi, Son; Malihi, Mehrdad; Hodge, David O.; Sit, Arthur J.

In: American Journal of Ophthalmology, Vol. 156, No. 5, 11.2013.

Research output: Contribution to journalArticle

@article{ec0f04600dab43b595939cbabc6ff39c,
title = "Clinical results of ab interno trabeculotomy using the trabectome for open-angle glaucoma: The mayo clinic series in Rochester, Minnesota",
abstract = "Purpose To determine outcomes of ab interno trabeculotomy for treatment of open-angle glaucoma (OAG). Design Retrospective interventional single-surgeon, single-center case series. Methods Data were collected from 246 patients undergoing ab interno trabeculotomy between September 1, 2006, and December 1, 2010, with 3 months' follow-up or longer. Kaplan-Meier analysis was performed using Criteria A (postoperative intraocular pressure [IOP] ≤21 mm Hg or ≥20{\%} reduction from preoperative IOP) and Criteria B (IOP ≤18 mm Hg and ≥20{\%} reduction in IOP). Failure included increased glaucoma medications or subsequent surgery. Failure risk factors were identified using Cox proportional hazards ratio (HR). Results Of 88 cases of ab interno trabeculotomy-only and 158 cases of ab interno trabeculotomy with cataract extraction, the retention rate was 70{\%} for 1 year and 62{\%} for 2 years. Preoperative mean IOP was 21.6 ± 8.6 mm Hg; the number of glaucoma medications was 3.1 ± 1.1. At 24 months postoperatively, mean IOP was reduced 29{\%} to 15.3 ± 4.6 mm Hg (P < 0.001) and the number of glaucoma medications was reduced 38{\%} to 1.9 ± 1.3 (P < 0.001) with a success rate of 62{\%} (95{\%} CI, 56{\%}-68{\%}) using Criteria A and 22{\%} (95{\%} CI, 16{\%}-29{\%}) using Criteria B. Failure risk factors using Criteria A included primary OAG (HR 3.14, P < 0.01, 95{\%} CI, 1.91-5.17) and past argon laser trabeculoplasty (HR 1.81, P < 0.01, 95{\%} CI, 1.18-2.77). Using Criteria B, the HR for pseudoexfoliative glaucoma was 0.43 (P < 0.01, 95{\%} CI 0.27-0.67). Of the cases, 66 (26.8{\%}) required subsequent surgery on an average of 10 months (2 days to 3.2 years) after ab interno trabeculotomy. Conclusions For criteria involving IOP ≤18 mm Hg, the 24-month survival of ab interno trabeculotomy is low. This surgery is appropriate for patients requiring a target IOP of 21 mm Hg or above.",
author = "Yachna Ahuja and {Ma Khin Pyi}, Son and Mehrdad Malihi and Hodge, {David O.} and Sit, {Arthur J}",
year = "2013",
month = "11",
doi = "10.1016/j.ajo.2013.06.001",
language = "English (US)",
volume = "156",
journal = "American Journal of Ophthalmology",
issn = "0002-9394",
publisher = "Elsevier USA",
number = "5",

}

TY - JOUR

T1 - Clinical results of ab interno trabeculotomy using the trabectome for open-angle glaucoma

T2 - The mayo clinic series in Rochester, Minnesota

AU - Ahuja, Yachna

AU - Ma Khin Pyi, Son

AU - Malihi, Mehrdad

AU - Hodge, David O.

AU - Sit, Arthur J

PY - 2013/11

Y1 - 2013/11

N2 - Purpose To determine outcomes of ab interno trabeculotomy for treatment of open-angle glaucoma (OAG). Design Retrospective interventional single-surgeon, single-center case series. Methods Data were collected from 246 patients undergoing ab interno trabeculotomy between September 1, 2006, and December 1, 2010, with 3 months' follow-up or longer. Kaplan-Meier analysis was performed using Criteria A (postoperative intraocular pressure [IOP] ≤21 mm Hg or ≥20% reduction from preoperative IOP) and Criteria B (IOP ≤18 mm Hg and ≥20% reduction in IOP). Failure included increased glaucoma medications or subsequent surgery. Failure risk factors were identified using Cox proportional hazards ratio (HR). Results Of 88 cases of ab interno trabeculotomy-only and 158 cases of ab interno trabeculotomy with cataract extraction, the retention rate was 70% for 1 year and 62% for 2 years. Preoperative mean IOP was 21.6 ± 8.6 mm Hg; the number of glaucoma medications was 3.1 ± 1.1. At 24 months postoperatively, mean IOP was reduced 29% to 15.3 ± 4.6 mm Hg (P < 0.001) and the number of glaucoma medications was reduced 38% to 1.9 ± 1.3 (P < 0.001) with a success rate of 62% (95% CI, 56%-68%) using Criteria A and 22% (95% CI, 16%-29%) using Criteria B. Failure risk factors using Criteria A included primary OAG (HR 3.14, P < 0.01, 95% CI, 1.91-5.17) and past argon laser trabeculoplasty (HR 1.81, P < 0.01, 95% CI, 1.18-2.77). Using Criteria B, the HR for pseudoexfoliative glaucoma was 0.43 (P < 0.01, 95% CI 0.27-0.67). Of the cases, 66 (26.8%) required subsequent surgery on an average of 10 months (2 days to 3.2 years) after ab interno trabeculotomy. Conclusions For criteria involving IOP ≤18 mm Hg, the 24-month survival of ab interno trabeculotomy is low. This surgery is appropriate for patients requiring a target IOP of 21 mm Hg or above.

AB - Purpose To determine outcomes of ab interno trabeculotomy for treatment of open-angle glaucoma (OAG). Design Retrospective interventional single-surgeon, single-center case series. Methods Data were collected from 246 patients undergoing ab interno trabeculotomy between September 1, 2006, and December 1, 2010, with 3 months' follow-up or longer. Kaplan-Meier analysis was performed using Criteria A (postoperative intraocular pressure [IOP] ≤21 mm Hg or ≥20% reduction from preoperative IOP) and Criteria B (IOP ≤18 mm Hg and ≥20% reduction in IOP). Failure included increased glaucoma medications or subsequent surgery. Failure risk factors were identified using Cox proportional hazards ratio (HR). Results Of 88 cases of ab interno trabeculotomy-only and 158 cases of ab interno trabeculotomy with cataract extraction, the retention rate was 70% for 1 year and 62% for 2 years. Preoperative mean IOP was 21.6 ± 8.6 mm Hg; the number of glaucoma medications was 3.1 ± 1.1. At 24 months postoperatively, mean IOP was reduced 29% to 15.3 ± 4.6 mm Hg (P < 0.001) and the number of glaucoma medications was reduced 38% to 1.9 ± 1.3 (P < 0.001) with a success rate of 62% (95% CI, 56%-68%) using Criteria A and 22% (95% CI, 16%-29%) using Criteria B. Failure risk factors using Criteria A included primary OAG (HR 3.14, P < 0.01, 95% CI, 1.91-5.17) and past argon laser trabeculoplasty (HR 1.81, P < 0.01, 95% CI, 1.18-2.77). Using Criteria B, the HR for pseudoexfoliative glaucoma was 0.43 (P < 0.01, 95% CI 0.27-0.67). Of the cases, 66 (26.8%) required subsequent surgery on an average of 10 months (2 days to 3.2 years) after ab interno trabeculotomy. Conclusions For criteria involving IOP ≤18 mm Hg, the 24-month survival of ab interno trabeculotomy is low. This surgery is appropriate for patients requiring a target IOP of 21 mm Hg or above.

UR - http://www.scopus.com/inward/record.url?scp=84886089972&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84886089972&partnerID=8YFLogxK

U2 - 10.1016/j.ajo.2013.06.001

DO - 10.1016/j.ajo.2013.06.001

M3 - Article

C2 - 23954209

AN - SCOPUS:84886089972

VL - 156

JO - American Journal of Ophthalmology

JF - American Journal of Ophthalmology

SN - 0002-9394

IS - 5

ER -